1. Home
  2. MRVI vs MVF Comparison

MRVI vs MVF Comparison

Compare MRVI & MVF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRVI
  • MVF
  • Stock Information
  • Founded
  • MRVI 2014
  • MVF 1988
  • Country
  • MRVI United States
  • MVF United States
  • Employees
  • MRVI N/A
  • MVF N/A
  • Industry
  • MRVI Biotechnology: Pharmaceutical Preparations
  • MVF Investment Bankers/Brokers/Service
  • Sector
  • MRVI Health Care
  • MVF Finance
  • Exchange
  • MRVI Nasdaq
  • MVF Nasdaq
  • Market Cap
  • MRVI 449.6M
  • MVF 395.0M
  • IPO Year
  • MRVI 2020
  • MVF N/A
  • Fundamental
  • Price
  • MRVI $3.69
  • MVF $6.88
  • Analyst Decision
  • MRVI Buy
  • MVF
  • Analyst Count
  • MRVI 7
  • MVF 0
  • Target Price
  • MRVI $4.54
  • MVF N/A
  • AVG Volume (30 Days)
  • MRVI 1.6M
  • MVF 162.8K
  • Earning Date
  • MRVI 11-06-2025
  • MVF 01-01-0001
  • Dividend Yield
  • MRVI N/A
  • MVF 4.11%
  • EPS Growth
  • MRVI N/A
  • MVF N/A
  • EPS
  • MRVI N/A
  • MVF N/A
  • Revenue
  • MRVI $192,435,000.00
  • MVF N/A
  • Revenue This Year
  • MRVI N/A
  • MVF N/A
  • Revenue Next Year
  • MRVI $7.27
  • MVF N/A
  • P/E Ratio
  • MRVI N/A
  • MVF N/A
  • Revenue Growth
  • MRVI N/A
  • MVF N/A
  • 52 Week Low
  • MRVI $1.67
  • MVF $5.85
  • 52 Week High
  • MRVI $6.21
  • MVF $7.19
  • Technical
  • Relative Strength Index (RSI)
  • MRVI 61.86
  • MVF 39.29
  • Support Level
  • MRVI $3.37
  • MVF $6.85
  • Resistance Level
  • MRVI $3.76
  • MVF $6.92
  • Average True Range (ATR)
  • MRVI 0.25
  • MVF 0.05
  • MACD
  • MRVI 0.05
  • MVF -0.01
  • Stochastic Oscillator
  • MRVI 94.02
  • MVF 16.71

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About MVF Blackrock MuniVest Fund Inc.

Blackrock Munivest Fund Inc is an investment management firm. Its investment objective is to provide current income exempt from regular U.S. federal income tax. The company invests in various sectors such as Health; Transportation; Utilities; Education; Tobacco; Housing and others.

Share on Social Networks: